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Abstract The number of harvested lymph nodes when
performing sentinel lymph node (SLN) biopsy remains
controversial. The aim of this study was to examine the
maximum number of nodes to be harvested for histopathol-
ogical analysis. We also wanted to determine if the level of
radioactivity within a SLN or its size were indicators for the
likelihood of nodal metastases. The SLNs from 34 neck
dissection specimens from patients with T1/T2 N0 oral and
oropharyngeal carcinomas were included. Altogether 76
SLNs were measured for radioactivity and lymph node
dimensions and volume. Tumour was identiWed in 16 of 76
nodes (positive nodes), and the remaining 60 nodes were
free from tumour (negative nodes). In 9 of 16 cases, metas-
tases were in the hottest node. Two patients had more than
one positive SLN: the Wrst and fourth hottest in one and the
second and fourth hottest nodes in another contained
tumour. However, all patients would have been staged
accurately if only the hottest three sentinel nodes had been
retrieved. Lymph nodes that contained tumour had a greater
maximum diameter than non-metastatic SLNs. To stage the
neck accurately, only the three hottest lymph nodes
required sampling.
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Introduction
Sentinel lymph node (SLN) biopsy has shown to be highly
accurate in oral and oropharyngeal carcinomas [6, 10, 12].
One of the controversies surrounding SLN biopsy is how
many lymph nodes should be harvested and whether all
nodes identiWed as “sentinel” by dye and radiocolloid are
true sentinel nodes. If several lymph nodes are required to
be removed, the meaningfulness of SLN biopsy becomes
questionable.
Since some of the colloid particles move from SLN to
lymph nodes lower in the draining lymphatic basin, second
and subsequent echelon nodes may sometimes be regarded
as “sentinel nodes” [4]. It is not possible to determine by
mere location whether a radioactive or blue node is a true
Wrst echelon lymph node. For example, a node highlighted
by radiocolloid in level IV is as likely to be the Wrst eche-
lon node as is a lymph node in level II. Anatomically
lower nodes are not necessarily second echelon nodes,
unless eVerent lymphatics, visualized, for example, by
blue dye, can be seen draining from a node at a higher
level into one at a lower level. It is a misconception that
the Wrst echelon SLN is the most radioactive, and more
likely to contain a metastasis [13]. Moreover, SLNs which
are largely inWltrated by the tumour are less radioactive
[5]. Studies on melanoma show that little additional infor-
mation is gained by following the radiotracer more distal
to the primary site and removing more than two sentinel
nodes [7].
Large lymph nodes are more likely to contain tumour
than small lymph nodes, although it is known that a
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small lymph node may harbour a metastasis and a meta-
static lymph node is not always the largest one [2, 14].
To our knowledge, the relationship between the SLN
size and occurrence of nodal metastasis has not been
reported previously in head and neck squamous cell
carcinomas.
The primary aim of this study was to determine how
many nodes should be harvested to accurately stage the
neck. The secondary aim was to determine if the amount of
radioactivity within a SLN or the relative size of a SLN was
an indicator of the likelihood of nodal metastases.
Patients and methods
Patients
Thirty-one patients with previously untreated, clinically
staged as T1/T2 N0, oral and oropharyngeal carcinomas
were included. After harvesting the SLNs as described
below, all patients underwent either selective neck dissec-
tion (levels I–III n = 2; levels I–IV n = 12) or modiWed rad-
ical neck dissection (n = 20). Altogether, 34 neck
dissections were performed. Of the primary tumours 16
were in the tongue, seven in the Xoor of mouth, four in the
retromolar trigone, three in the palate and one in the
gingiva of the mandible.
Lymph nodes
All radioactive lymph nodes were harvested 20–24 h after
the injection of up to 40 MBq 99mTc labelled colloidal
human serum albumin to the tumour site. After removal,
radioactive SLNs were placed against the tip of the 14 mm
collimated probe of the Neoprobe-1500 (Neoprobe Corp,
Columbus, OH, USA) and a 10 s count was measured ex
vivo.
Radioactive sentinel nodes were Wxed in formalin and
thereafter the three-dimensions (the maximum diameter,
the middle diameter and the minimum diameter) of the
node were measured. The volume of the lymph node was
calculated using the formula: volume (in mm3)=4 / 3  (  r1
r2 r3), where r1, r2 and r3 were the radii of the three-dimen-
sions. Lymph nodes were bisected, and if the two halves
were thicker than 2 mm, further sections were processed at
2 mm intervals. A single block from each section was
examined using haematoxylin and eosin stain for the
presence of tumour within the sentinel node.
Only radioactive nodes were included in this study;
cold-blue SLNs (four in total, all non-metastatic) were not
analysed because the intensity of the colour cannot be
quantiWed in the same way as radioactivity. Altogether, 76
SLNs were harvested (range 1–6/neck side).
Statistics
For non-parametric tests, Mann–Whitney U test and Pear-
son’s correlation coeYcient were used. For parametric
tests, Student’s t test was used.
Ethics
The study was approved by the local research ethics com-
mittee and a written consent was obtained from all patients
Results
One or more hot (radioactive) SLNs were identiWed in 34
necks. Out of the 76 hot SLNs, 35 were hot only and 41
were hot and blue. Tumour was identiWed in 16 of 76 nodes
(positive nodes), and the remaining 60 nodes were free
from overt tumour (negative nodes). One hot node was
found in 14 necks, two hot nodes in eight, three hot nodes
in six, four hot nodes in three, Wve hot nodes in one and six
hot nodes in two necks. Histopathological examination
showed positive SLNs in 14 patients (14 necks), whereas
17 patients had negative SLNs only. Of the metastatic
nodes, 11 were hot and blue whereas Wve were hot only.
Radioactivity of SLNs
In those patients with positive sentinel nodes, the hottest
nodes were not always the nodes that contained tumour
(Table 1). There were two patients with more than one pos-
itive sentinel node. In these two, the second and fourth hot-
test nodes and the Wrst and fourth hottest nodes contained
tumour. In the rest of the 16 sentinel nodes that contained
tumour, no more than one node per patient contained
metastases. In 9 of 16 cases, the hottest node contained
metastases and in Wve cases, the hottest sentinel node did
not contain tumour despite the presence of tumour in
Table 1 The rank (per patient) of radioactive nodes with their
pathology
Radioactivity of the 
node in patients
Pathology of node Total
Non-metastatic Metastatic
Hottest node 25 9 34
Second hottest node 15 4 19
Third hottest node 11 1 12
Fourth hottest node 4 2 6
Fifth hottest node 3 3
Sixth hottest node 2 2
Total 60 16 76Eur Arch Otorhinolaryngol (2008) 265 (Suppl 1):S19–S23  S21
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another radioactive sentinel node. All patients would have
been staged accurately if only the hottest three sentinel
nodes had been retrieved.
The radioactivity of primary tumour sites between the
groups of positive and negative nodes was comparable;
there was no signiWcant diVerence between the groups
(Table 2). No correlation was detected between the radioac-
tivity of the SLN and that of the tumour site (Pearson’s
correlation coeYcient (r) = 0.08).
There was no diVerence in amount of radioactivity
between positive and negative sentinel nodes (p = 0.45)
(Table 2).
The dimensions of the SLNs
The maximum diameter of lymph nodes varied from 3 to
40 mm and the mean maximum diameter was 12.7 mm
(95% C.I.: 11.0–14.3 mm) (Fig. 1). The volume of sentinel
nodes varied from 3 to 6,409 mm3 and the mean volume
was 457 mm3 (95% C.I.: 249–664 mm3). The mean mini-
mum and mean middle diameter of sentinel nodes was 5.2
and 7.4 mm, respectively.
Lymph nodes that contained tumour had a greater maxi-
mum diameter than non-metastatic sentinel nodes (Figs. 1,
2, Table 2). The diVerence was highly signiWcant
(p < 0.001). A signiWcant diVerence was also detected in
the middle nodal dimension between positive and negative
SLNs (p < 0.05). However, when comparing the minimum
diameter or the volume of sentinel nodes for positive and
negative nodes, the diVerences were not statistically signiW-
cant. Even though the diVerence in the volume was large, it
was not statistically signiWcant (p =0 . 1 ;  T a b l e2).
The node with the largest maximum diameter was not
always the sentinel node that contained metastases
(Table 3). Although in 12 cases the node with the largest
maximum diameter was the node containing metastases, in
four cases, smaller nodes were the sentinel nodes which
contained tumour. Two patients had more than one positive
SLN in their neck: in one, the metastases were found in
the largest and second largest nodes and in the other, the
metastases were found in the largest and smallest (the
fourth largest) nodes. Only the largest and second largest SLNs
would have required sampling to stage the neck accurately.
Table 2 The characteristics 
related to the metastatic 
(positive) and non-metastatic 
(negative) SLNs
Positive SLNs Negative SLNs p value
Number of SLN 16 60
Tumour activity (mean; counts/10 s) 18,900 18,042 n.s.
Activity of SLN (mean; counts/10 s) 980 1,554 n.s.
Maximum diameter of SLN (mean in mm) 18 11 p <0 . 0 0 1
Range (mm) 7–40 3–34
95% C.I. of mean (mm) 13.4–22.3 9.7–12.8
Middle nodal dimension (mean in mm) 9.5 6.8 p <0 . 0 5
Minimum diameter of SLN (mean in mm) 6.3 4.9 n.s.
Volume of SLN (mean in mm3) 789 368 n.s.
SLN sentinel lymph node
Fig. 1 Comparison of maximum nodal diameters of the metastatic
(positive) and non-metastatic (negative) sentinel lymph nodes
Table 3 The rank of the maximum diametre of the sentinel node per
case compared with the pathology of the node
Maximum diametre 
of node per patient
Pathology of node Total
Non-metastatic Metastatic
Largest node 25 12 37
Second largest node 13 3 16
Third largest node 13 0 13
Fourth largest node 5 1 6
Fifth largest node 2 2
Sixth largest node 2 2
Total 60 16 76S22 Eur Arch Otorhinolaryngol (2008) 265 (Suppl 1):S19–S23
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Radioactivity versus dimensions of the SLNs
A comparison of the radioactivity of the SLN and nodal
volume or maximum nodal diameter showed almost no cor-
relation (Pearson’s correlation coeYcient (r) = 0.008 and
(r) = 0.28, respectively) (Fig. 3).
Discussion
This study was undertaken to determine whether nodal
radioactivity levels and SLN size could be used to predict
which nodes to sample in an oral cancer sentinel node
procedure. Within an individual case, the most radioactive
SLNs with large maximum diameters were more likely to
contain tumour than smaller, less radioactive nodes within
the case.
The absolute amount of radioactivity within a sentinel
node was no guide to the size of the node nor to the proba-
bility that the node contained tumour. However, within a
single patient the converse was true––to accurately stage
the neck, merely sampling the three hottest nodes would
have been suYcient. Also, in each single case, a biopsy of
the two largest SLNs would have been suYcient to accu-
rately stage the neck, and the two largest nodes were
always among the three hottest nodes.
More than one hot SLN was found in 20 cases. When the
amount of radioactivity within SLNs was analysed in each
patient, it was seen that the hottest nodes were more likely
to contain tumour and the largest SLNs were most likely to
be metastatic. Thus, in the 16 tumour containing SLNs,
nine were the hottest nodes, four were the second hottest
nodes and one was the third hottest node. The remaining
two hot nodes were weakly radioactive, but were found in
patients with more than one hot positive node. Our results
are in line with those by Werner et al. [13], who reported
that 39% of the cancer-positive necks would have been
missed if only the hottest node had been excised.
Concerning the size, 12 of the 16 positive nodes were the
largest sentinel nodes and three of the 16 were the second
largest nodes. In the one remaining case, the fourth largest
node contained tumour but it was also detected in a larger
SLN. Our aim was not to Wnd any speciWc size limit for
metastasis, but to see the relative size of the SLNs that con-
tained metastasis. It is known that very small lymph nodes
can harbour a metastasis and a metastatic lymph node is not
always the largest node in the neck dissection specimen [2,
3, 14]. It is also known that the nodal size of a SLN is an
inaccurate predictor of nodal metastases [1]. Radiological
criteria for metastatic lymph nodes have been assessed pre-
viously. “Central necrosis” caused by tumour involvement
is a highly reliable sign of metastasis and can be detected
also in small lymph nodes [2, 3]. DiVerent size criteria have
been assessed in large series, but any size criteria, whether
based on minimum or maximum dimensions or shape is
unreliable when the lymph node is roughly normal size [2,
3]. We made the measurements from the formalin Wxed
nodes. All nodes were, however, processed in a uniform
manner and the relative size is therefore unlikely to be
changed. Furthermore, in breast cancer tumour size can be
measured either from fresh or Wxed samples without aVect-
ing accuracy [8].
All necks were assessed clinically by palpation only.
This may have led to the large diameters of some of the
nodes we found in our results. Nevertheless, the accuracy in
this series was 100%. In addition, SLNs were not orien-
Fig. 2 Box plot comparing the maximum diameter of metastatic (pos-
itive) and non-metastatic (negative) sentinel lymph nodes, showing
statistical signiWcant diVerences
Fig. 3 A comparison of nodal volume and amount of radioactivity,
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tated, and so it is not possible to say whether these nodes
would have been deWned as malignant using radiological
criteria.
The total volume of the lymph node was not signiWcantly
diVerent between the two groups. This apparent paradox is
probably due to the power of the study sample––16 sentinel
nodes were found to contain tumour, in comparison to 60,
which were free from metastases.
Dynamic lymphoscintigraphy may sound like a suitable
method to distinguish the Wrst echelon nodes from other
lymph nodes and thus be used as a guide for selecting the
SLNs to be harvested. However, in the neck, it is not possi-
ble to distinguish whether a node appearing after the Wrst
one is really a second echelon node or if the later appear-
ance is due to the longer lymphatic pathways. We also
noticed that in cases of multiple SLNs all the nodes became
visible quite simultaneously.
Although the actual amount of radioactivity within a
sentinel node can only be estimated with a hand held
gamma probe, such as the Neoprobe, it can be considered
suYcient for the purposes of this study, since the hand held
gamma probe is also used clinically to determine the radio-
activity of the lymph nodes.
Blue dye was also used in search of SLNs in this series
of patients, but we did not study its use because the inten-
sity of the colour cannot be quantiWed in the same way as
radioactivity or size. However, it is noteworthy that only a
proportion of all SLNs as well as from metastatic nodes had
been regarded as blue, and none of the cold blue nodes
were metastatic. These Wndings support the conception that
blue dye can be considered optional in search of SLNs.
In the present study, the histopathological sections were
made by cutting the SLNs at 2 mm intervals only. Evidence
is now emerging over how to process SLNs but at the time
the study was performed all SLNs were processed in the
same way as all nodes in the neck.
All patients in our series had a neck dissection. The sen-
sitivity of the method at our unit has been reported previ-
ously, including the cohort within this patient population
[9, 11]. The aim of this study was not to focus on the non-
sentinel lymph nodes, but it is noteworthy that in this
patient series, consisting of T1 and T2 tumours, there were
no false positive nodes, nor have been any instances of dis-
ease persistence outside of the dissected Weld during the
follow-up of 5 years.
Conclusion
Our results indicate that for oral carcinomas it seems suY-
cient to harvest three of the hottest SLNs. Additionally,
metastases are more likely to be in large SLNs and in all
patients the necks would have been staged accurately as
positive or negative if only the two largest SLNs had been
retrieved. However, with the low power of this study, this
conclusion should be interpreted with caution.
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